Personalized Medical Care & Dedicated International Patient Concierge
Medical Guide
Repeat Botox or Filler Patient in Korea: What Differs
Medically reviewed by Dr. Byun Sung Ho, MD, Director, Toxnfill Hongdae A repeat Botox patient in Korea does not sit through the same consultation as a beginner, and neither does an
Schedule a ConsultationMedically reviewed by Dr. Byun Sung Ho, MD, Director, Toxnfill Hongdae
A repeat Botox patient in Korea does not sit through the same consultation as a beginner, and neither does anyone with previous filler experience. A Korea clinic visit for a returning patient turns on four questions a first-timer cannot be asked: what was injected, how much, when, and how your face responded. Toxnfill Hongdae asks patients to disclose previous cosmetic treatments before an injectable procedure, and for an experienced patient that disclosure is the raw material the dosage and product decisions are built from.
This guide covers what to bring, how existing product in the tissue changes the assessment, what switching brand changes, and how maintenance timing gets decided when you are flying in for it.
Why a Returning Patient's Consultation Starts Somewhere Else
It starts with your history rather than with your goal, because your history already narrows the options.
Toxnfill Hongdae describes its filler consultation as an assessment of facial structure, a discussion of volume targets, the choice of a suitable brand and density, and a personalized injection design. For botulinum toxin it describes a consultation that reviews your goal, how the target muscles move, the anatomy of the facial or body area involved, your history and medications, and the procedures you have had before — after which the practitioner decides whether treatment and the planned dose are appropriate.
Read those two descriptions as a first-time patient and "previous procedures" is one empty line on a form. Read them as a returning patient and it becomes the largest single input into the plan. What you report feeds:
- Whether an area needs product added, product removed, or nothing at all this visit.
- The density and brand chosen for each area, since density is matched to depth and to what is already there.
- The dose planned for muscle treatment, which the clinic decides at the consultation rather than carrying forward a number quoted elsewhere.
- Which areas are deferred because the previous product has not finished its course.
- Whether any part of the plan needs an enzyme step before anything new goes in.
The clinic also asks, ahead of filler treatment, that you inform the medical team about medication allergies, any history of antibiotic sensitivity, and underlying medical conditions. Its Belotero guidance names previous filler treatments explicitly, and its JUVEDERM guidance names past facial treatments alongside antibiotic allergies and bleeding disorders. The pattern is consistent across the injectable menu: your treatment history is clinical information, not trivia.
The Injectable History Worth Writing Down Before You Travel
Write it down before you leave, because the details you will be asked for fade from memory first.
MedlinePlus, the consumer health service of the US National Library of Medicine, recommends keeping a personal health record and lists the fields worth holding: dates and results of tests, major illnesses and procedures with their dates, medicines and supplements with dosages and how long you have taken them, and any allergies. A version of that template for an aesthetic consultation contains:
- The product name for every injection you have had, as printed on the syringe or the receipt, not the category.
-The dose or volume, in whatever unit your previous clinic recorded it, plus which product that unit belonged to.
-The date of each session, and the date of the most recent one in particular.
-The exact areas treated, including areas you asked about but that were treated indirectly.
-How long the result lastedbefore you noticed it fading, area by area, since areas differ.
-How the result felt— too strong, too weak, uneven, heavy in the brow, or exactly right.
-Any reaction at all, including prolonged bruising or swelling, lumps you could feel, or a cold sore that appeared after a lip treatment.
-Whether any filler has ever been dissolved, when, and how completely.
-Known allergies, with particular attention to local anesthetics, antibiotics, and any previous reaction to an injection of any kind.
If You Cannot Name the Product
Bring what you do have. Dated photographs from before and after each previous session let the clinician separate your baseline anatomy from what product has been doing, and a printout from your previous clinic's record carries the product name even when your memory does not. Failing both, the treated areas and approximate dates still tell a clinician a great deal. You can send your previous treatment details ahead of the visit so the consultation begins with them in hand.
What Already Sits in Your Tissue Changes the Assessment
An area that looks filled is not necessarily an area that still contains much filler, and that single fact reshapes the whole examination.
StatPearls, the peer-reviewed clinical reference published on the National Library of Medicine's NCBI Bookshelf, describes a process it calls isovolumetric degradation. As a cross-linked hyaluronic acid gel breaks down in the tissue, water gradually takes the place of the gel, leaving a progressively more dilute gel occupying much the same volume. So a cheek can still look supported while the product doing the supporting is largely spent, which is why "it still looks fine" is a conclusion better reached by examination than by mirror.
The same reference notes that hyaluronic acid gel fillers differ from one another in concentration, particle size, cross-linking density, stated duration, and whether they contain lidocaine. It adds that high-density, large-particle products are directed at deep dermal placement while low-density, small-particle products are directed at fine lines. A clinician planning a second layer therefore needs to know what kind of gel is already there and at what depth.
Toxnfill Hongdae's own approach to assessing residual product is stated in the context of its hyaluronidase treatment: the clinician should identify the type, location and amount of hyaluronic acid filler present before determining what to do about it. The clinic notes that ultrasound guidance may occasionally be used to locate deep filler deposits that are not obvious on the surface. Its stated reason for asking which brand was previously injected is the same reason it matters to you: different gels behave differently once they are in place.
A returning patient is not being assessed against a blank canvas, and the technique choices follow from that.
Continuity or a Switch: What Changing Filler Brand Actually Changes
Changing brand changes the product's engineering, its regulatory identity and possibly its anesthetic content, so it is a decision worth making deliberately.
Start with the regulatory picture, because it is public and checkable. Hyaluronic acid dermal fillers are regulated in the United States as Class III medical devices and reach the market through premarket approval, the FDA's most demanding device pathway. The FDA's premarket approval database recordsRESTYLANE INJECTABLE GELunder PMA number P040024, applicant Q-Med AB, with a decision date of March 25, 2005, and an approval order indicating the device for mid-to-deep dermal implantation to correct moderate to severe facial wrinkles and folds such as nasolabial folds. The same database recordsJUVEDERM 24HV, JUVEDERM 30 and JUVEDERM 30HV gel implants under PMA number P050047, applicant Allergan, with a decision date of June 2, 2006, and an approval order indicating injection into the mid to deep dermis for the same correction. Both records sit under one product code, described generically as an implant, dermal, for aesthetic use.
So these are separate approvals for separate devices, each with its own indicated placement depth. Swapping one for the other is not a flavor change, and the approval language tells you where each product is indicated to go.
Toxnfill Hongdae's stated selection process is to choose the filler brand and density to suit the treatment area, the facial anatomy and the result being sought, and it describes its individual products in terms of engineering properties: cohesiveness, cross-linking, water absorption, holding power and resistance to spreading after placement.
Two practical points follow. First, if you were happy with a previous product in a specific area, say which product and which area, because that pairing is the useful unit of information. Second, several imported hyaluronic acid fillers carry lidocaine within the gel for comfort — Toxnfill Hongdae notes this for JUVEDERM and for Atiere, and StatPearls lists hypersensitivity to lidocaine as a contraindication for products containing it. If an injection has ever left you feeling unwell inexplicably, establish the anesthetic content of the product you had before switching to or from a lidocaine-containing gel.
Dosage Planning Guided by How You Responded Last Time
Your previous response is evidence, and it is the one form of evidence a first-time patient cannot supply.
Toxnfill Hongdae states that its botulinum toxin treatment can be customized by injection area, product and dose, and that frequency is set according to the individual patient's condition. It also asks patients to discuss previous botulinum toxin treatments and their expectations at the consultation. The clinic is not looking for a number to reuse; it is looking for a response pattern to plan against.
What is worth reporting, precisely:
- Which muscles or areas were treated, and which were deliberately left alone.
- Whether movement returned sooner or later than you were told to expect.
- Whether any brow, eyelid or smile change felt heavier than you wanted.
- Whether the two sides behaved differently from each other.
- Whether you felt the effect had worn off completely before your next session, or only partly.
That last point is the one experienced patients most often skip, and it is directly relevant. Being re-treated while a previous effect is still partly present poses a different planning question than always waiting for full movement to return.
For filler, the equivalent report is about shape rather than movement: which areas held their result, which faded first, whether anything looked heavier on one side over time, and whether any area ever felt firm or lumpy. The clinic's stated method is to select filler type, injection location and technique according to the treatment area, the anatomy and the intended result — a plan that improves with better input.
Timing Maintenance Around a Trip
The timing question has two halves: when the previous product is due to be topped up, and how many days the visit itself needs.
On the first half, the numbers depend on the product. StatPearls states that the duration of a hyaluronic acid filler depends on the injection location, the specific product and the injection technique, and that longevity is governed by particle size in particulate-manufactured gels and by cross-linking density in non-particulate ones. Toxnfill Hongdae's general guidance for its standard listed fillers is a maintenance period of roughly six to twelve months, and it states plainly that longevity varies with the person, the treated area and the product. For specific imported products it gives longer bands: JUVEDERM at twelve to twenty-four months, with Restylane and Belotero each put at roughly six to eighteen. Rejuviel is described as typically lasting six to twelve months, certain high-stability formulations reaching twelve to eighteen.
For muscle treatment the clinic's position is that the effect is temporary and that a further session may be needed once muscle activity returns, with frequency customized to the individual. Nobody can hand you a fixed calendar for that, which is exactly why your own record of how long previous sessions lasted is the most useful thing you can bring.
On the second half, the visit itself is short. The clinic lists filler treatment at approximately ten to twenty minutes of injection following topical numbing, in a single visit, with an immediate return to ordinary daily activity. It states that the final appearance is best judged once initial swelling has settled, commonly within one to two weeks, that international patients may prefer to allow several days for early swelling to subside, and that flying may be possible soon after treatment though twenty-four to forty-eight hours or more can be preferable depending on the area.
So book the assessment early in the stay, leaving room for a second appointment if the examination suggests staging the work. You can arrange a review of existing filler placement before committing to a treatment date.
If the Previous Result Has to Come Out First
Sometimes the honest plan is subtraction before addition, and that is its own procedure with its own history to disclose.
StatPearls describes hyaluronidase as an enzyme that temporarily and reversibly depolymerizes hyaluronic acid, reducing the viscosity of the extracellular matrix, and lists reversal of hyaluronic-acid-based cosmetic fillers among its off-label uses. The FDA-approved prescribing information for Amphadase, published in the National Library of Medicine's DailyMed database, describes a preparation of purified bovine testicular hyaluronidase at 150 USP units per milliliter, gives hypersensitivity to the enzyme or any ingredient as a contraindication, and warns against injection into or around an infected or acutely inflamed area because of the risk of spreading infection.
Now the part specific to people who have been here before. A 2024 systematic review summarized in the StatPearls chapter identified prior hyaluronidase exposure, along with sensitization through insect or wasp venom, as potential risk factors for an allergic response to the enzyme; the chapter puts overall reported allergy rates below 0.1% of treated individuals, and notes that animal-derived hyaluronidase is immunogenic. If filler has ever been dissolved for you, anywhere, that disclosure carries direct clinical weight.
One sequencing detail follows from the same source: hyaluronidase accelerates the onset of local anesthetics and shortens their duration — worth knowing if enzyme and filler work are discussed for one appointment.
Toxnfill Hongdae's stated approach lines up with all of this. It asks to be told the specific brand of filler previously injected, and advises discontinuing blood thinners, alcohol and aspirin beforehand to reduce bruising. It describes micro-dosing the enzyme into precise target areas so that dissolving is not uneven, and notes that excessive dissolution can result in temporary volume loss or contour change — which is the reason micro-dosing matters. On the question every patient asks next, its stated approach is to re-inject fresh hyaluronic acid filler one to two weeks after dissolving is fully complete, with adjustment appointments available on the same one-to-two-week horizon.
Experience Does Not Lower the Risk Floor
Several uneventful previous treatments are reassuring about your tolerance and say nothing about the risk profile of the next injection.
StatPearls sets out the serious but rare complications of hyaluronic acid filler plainly. Infection follows bacterial inoculation through the injection site and is addressed by aseptic technique and by not injecting near an active infection. Tissue necrosis can follow vascular occlusion when filler enters an artery, which is why anatomical knowledge and aspiration matter, and why hyaluronidase should be applied immediately if it is suspected.
One item on that list is written specifically for repeat patients. StatPearls states that before lip injection it is important to know whether the patient has a history of herpes simplex virus infection, or a history of reactivation after a previous filler injection, because the trauma of injection can trigger it — and that this is both preventable and treatable with oral acyclovir. A cold sore that appeared after a previous lip treatment is therefore not an embarrassing anecdote. It is actionable history, and it only exists if you have been treated before.
Toxnfill Hongdae's own account is that bruising, swelling, pain and a foreign-body sensation may occur and generally settle within one to two weeks, that vascular occlusion or severe inflammation is rare, and that persistent discoloration, blistering, itching, warmth or worsening pain should be reported to the clinic. That instruction applies on your fifth treatment exactly as on your first.
Photographs as a Running Record
The clinic builds a photographic record around each filler session, and for a returning patient that record compounds in value.
Toxnfill Hongdae describes its filler workflow as including a pre-procedure photo session, topical or local anesthesia, custom area mapping and design, the injection, and a post-treatment photo review. On a first visit those images are a baseline. On a second and third they become a series, and a series is what distinguishes product fading from ordinary change in the face underneath. Photographs from treatments elsewhere are worth adding to that set. You can also read the practice's own overview of its treatment categories to see which injectable programs are offered.
What to Ask, as Someone Who Has Done This Before
These questions only make sense from an experienced patient, which is why they are worth asking:
- What did you find on examination of the areas I have had treated before, and how much product do you think is still active?
- Are you recommending we add to what is there, or reduce it first?
- Which brand and density are you planning for each area, and is that the same class of product I had before?
- Does the product you are proposing contain a local anesthetic?
- Given how my last treatment behaved, are you planning a different dose or a different distribution?
- What should I record after this session so my next consultation is easier?
The Bottom Line
- Toxnfill Hongdae asks patients to disclose previous cosmetic treatments, previous fillers and previous botulinum toxin treatments, and for a returning patient that disclosure drives the product, dose and staging decisions.
- Bring specifics rather than categories: product names, doses with the product they belonged to, dates, areas, how long each result lasted, and any reaction — including any previous dissolving, which StatPearls links to a higher chance of an allergic response to the enzyme.
- Existing filler changes the assessment, because a hyaluronic acid gel dilutes as it degrades while occupying similar volume, so an area can look supported while the product is largely spent.
- Switching brand means moving between separately approved devices with their own indicated depths and possibly different anesthetic content, so name the product and the area you were happy with, not the brand alone.
Frequently Asked Questions
I already have filler from another clinic. Can more be placed on top of it?
That is settled by examination. Toxnfill Hongdae's stated method is for the clinician to establish the type, location and amount of hyaluronic acid filler already present before deciding what to do, and it notes that ultrasound guidance may occasionally be used to find deep deposits. The consultation then assesses facial structure and volume targets and selects the brand and density for each area.
What exactly should I tell the doctor about my previous treatments?
Toxnfill Hongdae asks patients to inform the doctor about allergies, medications, previous fillers, medical conditions and recent cosmetic treatments. The most useful version of that is specific: product names, the areas treated, the dates, the dose and the product it belonged to, how long the result held, and anything unusual that followed.
Can I switch to a different filler brand at this visit?
Yes, and brand selection is part of the consultation rather than a fixed default. The clinic's stated process is to choose the filler brand and density according to the treatment area, the anatomy and the intended result. StatPearls notes that hyaluronic acid gels differ in concentration, particle size, cross-linking density and lidocaine content, so a switch genuinely changes the product's properties.
How soon after my last filler should I come back?
That depends on the product and the area, and the clinic says so directly: longevity varies with the person, the treated area and the product. Its general guidance for its standard listed fillers is roughly six to twelve months of maintenance; for JUVEDERM it gives twelve to twenty-four months, and Restylane and Belotero are each put at about six to eighteen. An examination turns those bands into a date for you.
I have had filler dissolved before. Does that matter now?
Yes, and it is worth stating early. The StatPearls chapter on hyaluronidase reports that a 2024 systematic review identified prior hyaluronidase exposure as a potential risk factor for an allergic response to the enzyme, alongside sensitization through insect or wasp venom, with overall reported allergy rates below 0.1%. Toxnfill Hongdae separately asks to be told which filler brand was previously injected.
Do I need to allow extra days in Korea for a maintenance visit?
The treatment itself is short — roughly ten to twenty minutes of injection after topical numbing, in a single visit, with an immediate return to ordinary activity. The clinic's guidance is that the final appearance is best judged once early swelling settles, commonly within one to two weeks, and that flying is often possible soon afterward, though twenty-four to forty-eight hours or more can be preferable depending on the area.
Will the doctor simply repeat the dose I had at home?
The dose is set at this consultation. Toxnfill Hongdae states that botulinum toxin treatment is customized by injection area, product and dose, and that frequency is set according to the individual patient's condition, with the practitioner determining whether the planned dose is appropriate after evaluating the goal, the muscle activity and the anatomy. Your report of how a previous session behaved is an input to that decision rather than a substitute for it.
This article is for general informational purposes and does not constitute individualized medical advice, and it is not a self-diagnosis tool. Treatment candidacy, product selection, dosing and expected outcomes for a returning injectable patient can only be determined through a consultation with a qualified dermatologist.
Clinical Notice: Individual treatment outcomes and recovery timelines may vary depending on skin condition and personal physiology. Temporary redness, mild swelling, or bruising may occur after treatment; a pre-procedure physician consultation is always conducted.
More Articles
Continue reading our clinical guides.
Toxnfill Hongdae Dermatologist: Meet Dr. Chang Ye Ji
Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae The lead dermatologist at Toxnfill Hongdae is Dr. Chang Ye Ji, who serves as the branch's Chief Director
Learn More
Korean Dermatology Residency Training: How Doctors Qualify
Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae Korean dermatology residency training follows a sequence that will look broadly familiar to an American
Learn More
In-Person Consultation at a Korean Dermatology Clinic
Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae An in person consultation at a Korea dermatology clinic is a working appointment with a defined shape: h
Learn More